|

Compliant Analysis of Patient Samples and Data

RECRUITINGSponsored by Sequenom, Inc.
Actively Recruiting
SponsorSequenom, Inc.
Started2018-03-17
Est. completion2030-03-17
Eligibility
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04364503

Summary

Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Arm 1
* All samples and data are de-identified and HIPAA compliant
* Arm 2
* Subject is of scientific interest to the Sponsor or treating physician
* Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected.

Exclusion Criteria:

* Arm 1
* Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development
* Arm 2
* Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent

Conditions3

CancerInfectious DiseasePregnancy Related

Locations1 site

Sequenom, Inc
San Diego, California, 92121
Graham P McLennan, MS(858) 202-2000mclenng@labcorp.com

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.